Association of Polybrominated Diphenyl Ethers (PBDEs) and Polychlorinated Biphenyls (PCBs) with Hyperthyroidism in Domestic Felines, Sentinels for Thyroid Hormone Disruption. by Walter, Kyla M et al.
UC Davis
UC Davis Previously Published Works
Title
Association of Polybrominated Diphenyl Ethers (PBDEs) and Polychlorinated Biphenyls 
(PCBs) with Hyperthyroidism in Domestic Felines, Sentinels for Thyroid Hormone 
Disruption.
Permalink
https://escholarship.org/uc/item/1x10m5pj
Journal
BMC Veterinary Research, 13(1)
Authors
Walter, Kyla
Lin, Yan-Ping
Kass, Philip
et al.
Publication Date
2017-05-03
DOI
10.1186/s12917-017-1031-6
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
RESEARCH ARTICLE Open Access
Association of Polybrominated Diphenyl
Ethers (PBDEs) and Polychlorinated
Biphenyls (PCBs) with Hyperthyroidism in
Domestic Felines, Sentinels for Thyroid
Hormone Disruption
Kyla M. Walter1, Yan-ping Lin1, Philip H. Kass2 and Birgit Puschner1*
Abstract
Background: Hyperthyroidism is the most common endocrine disorder observed in domestic felines; however, its
etiology is largely unknown. Two classes of persistent organic pollutants, polybrominated diphenyl ethers (PBDEs)
and polychlorinated biphenyls (PCBs) are known to interfere with thyroid hormone (TH) signaling and regulation;
thus, it is postulated that they contribute to the etiopathogenesis of feline hyperthyroidism and pose a risk to
humans and other species. In this case-control study, the concentrations of 13 PBDE and 11 PCB congeners were
measured by gas chromatography mass spectrometry in serum or plasma samples from 20 hyperthyroid and 31
control cats in order to investigate the association between concentration of PBDE and PCB congeners and feline
hyperthyroidism. Logistic regression analysis was used to determine whether elevated concentrations of individual
congeners were associated with a higher risk of feline hyperthyroidism.
Results: Hyperthyroid cats had higher concentrations of four PBDE congeners (BDE17, BDE100, BDE47, and BDE49)
and five PCB congeners (PCB131, PCB153, PCB174, PCB180, and PCB196), compared to control cats. In addition, the
sum of both PBDE and PCB congener concentrations were elevated in the hyperthyroid group compared to control
cats; however, only the increased PCB concentrations were statistically significant. The sum total PBDE
concentrations in our feline samples were approximately 50 times greater than concentrations previously reported
in human populations from a geographically similar area, whereas sum total PCB concentrations were comparable
to those previously reported in humans.
Conclusions: These observational findings support the hypothesis that PBDEs and PCBs may contribute to the
etiopathogenesis of hyperthyroidism in felines. As domestic house cats are often exposed to higher concentrations
of PBDEs than humans, they may serve as sentinels for the risk of TH disruption that these pollutants pose to
humans and other species.
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Background
Hyperthyroidism is recognized as the most common fe-
line endocrinopathy and is a major cause of morbidity
in middle-aged and elderly cats [1]. Feline hyperthy-
roidism (FH) was first described as a distinct disorder
in 1979 [2, 3] and has since increased consistently in
prevalence [4, 5]. It is currently estimated to affect over
10% of elderly cats; however, prevalence varies geo-
graphically [1, 6]. Feline hyperthyroidism is clinically
similar to toxic nodular goiter in humans, both being
caused by adenomatous nodular hyperplasia of the thyroid
gland [7, 8]. While the pathology of feline hyperthyroidism
has been thoroughly characterized [7, 9–13], the etiology
of the disorder is largely unknown. Several epidemiologic
studies have attempted to identify risk factors associated
with FH; however, a single dominant causal factor has not
been identified. The scientific literature strongly supports
that FH is a complex multifactorial disorder with a signifi-
cant environmental component [4, 5, 14–18]. As domestic
cats and their human owners share their environment, it
is probable that environmental factors that contribute to
FH may also adversely impact the thyroid health of
humans and other animal species.
It has been hypothesized that exposure to thyroid-
disrupting chemicals in the environment may cause thyroid
gland dysfunction and contribute to the pathogenesis of
FH. A number of environmental contaminants disrupt thy-
roid hormone (TH) signaling and homeostasis at multiple
levels of hormone action, including two classes of persistent
organic pollutants found in high levels in the environment:
polychlorinated biphenyls (PCBs) and polybrominated
diphenyl ethers (PBDEs). Given that PCBs and PBDEs are
known TH disruptors, environmental exposure to these
compounds may contribute to the development of thyroid
hyperplasia, leading to hyperthyroidism. Both PCBs and
PBDEs have high chemical and thermal stability, making
them useful for a number of commercial applications. PCBs
were widely used, beginning in the 1920s, as electrical insu-
lators in transformers, capacitors, and heat exchangers, and
as stabilizers in paints, plastics, and rubber products [19].
Major production of PBDEs began in the early 1970s,
shortly before FH was initially reported, for use as flame
retardants in electronics, home furnishings, and foam
products, including pet toys and bedding [20–22]. While
commercial production of PCBs was banned in 1979 and
two commercial formulations of PBDEs (pentaBDE and
octaBDE) were banned or phased out of production in
some states in the U.S. in 2006, these compounds remain
ubiquitous environmental pollutants due to their resistance
to degradation and ability to bioaccumulate in human and
animal tissues [23, 24]. Previous studies have reported
serum PBDE concentrations in cats that are 10–100 fold
greater than median levels measured in adult human popu-
lations from their respective countries [25–28]. Therefore,
domestic cats may serve as sentinels for adverse health con-
sequences associated with exposure to these environmental
contaminants.
PCBs and PBDEs each consist of a total of 209
congeners with varying degrees of chlorination and
bromination, respectively, and the effects of individual
congeners and their metabolites on TH signaling and
regulation are not well understood. While these com-
pounds may derive some of their toxicity from their
structural similarity to thyroid hormones thyroxine (T4)
and triiodothyronine (T3) (Fig. 1), a wide range of conge-
ners must be evaluated for potential association with FH.
The goal of this study was to investigate whether elevated
serum or plasma concentrations of select PBDE and/or
PCB congeners are associated with FH to further examine
the hypothesis that these persistent pollutants may con-
tribute to the pathogenesis of FH.
Methods
Study population
Plasma and serum samples were obtained from client-
owned cats visiting the University of California Davis
William R. Pritchard Veterinary Medical Teaching
Hospital (VMTH) (Davis, CA, USA) during 2012 and
2013 for routine appointments. Samples were stored
at −20 °C prior to analysis. Hyperthyroidism was diag-
nosed on the basis of consistent clinical signs observed by
a VMTH clinician and total serum T4 concentrations
measured above the reference range of 1.1–3.3 μg/dl. Both
Fig. 1 Chemical structures of the thyroid hormone thyroxine (T4),
polychlorinated biphenyls (PCBs), and polybrominated diphenyl
ethers (PBDEs)
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newly diagnosed cases of FH and cats receiving treatment
for previously diagnosed FH were included in the study;
however, all reported T4 values were from the time of
diagnosis. Control samples were collected randomly from
feline patients presented to the VMTH for routine ap-
pointments and determined to be free of FH based on the
absence of clinical signs of hyperthyroidism or any other
endocrine disease. In total, 20 hyperthyroid cats and 31
control cats were included in the analysis. Written consent
was obtained from all owners to permit use of their cats’
samples in the study.
Extraction of analytes
Samples were stored at −20 °C and thawed on ice prior to
extraction. The method used for the extraction of PBDE
and PCB analytes and the materials used for extraction
have been detailed previously [29]. Briefly, 0.5 ml aliquots
of serum or plasma were mixed with 0.5 ml of pure formic
acid, ultrasonicated for 10 min, and filtered gravimetrically
through Waters Oasis HLB SPE cartridges (Milford, MA,
USA), which had been previously conditioned with metha-
nol and ultrapure water with formic acid and methanol (v/
v/v, 94.5/0.5/5). SepPak cartridges (Sep-pak® Light Silica
cartridges, Waters, Milford, MA, USA) were placed be-
neath SPE columns and analytes were eluted with three
washes of 3 ml dichloromethane under vacuum. Eluents
were collected in disposable glass tubes containing 100 μL
of 1 ng/ml Mirex as an internal standard to evaluate instru-
ment performance. Samples were dried in a water bath
(40 °C) using a nitrogen evaporator (Organomation Associ-
ates, Inc., Berlin, MA, USA), reconstituted in 100 μl of iso-
octane, and transferred into auto-sampler vials for analysis.
13C12 labeled 2,3′,4,4′,5-Penta BDE (
13C12−BDE-118) and
13C12 labeled 2,2′,3′,4,5-Pentachlorobiphenyl (13C12-PCB-
97) were used as surrogate internal standards throughout
the extraction and analytical procedures (Cambridge
Isotope Laboratories, Inc., Tewksbury, MA, USA). Nine
calibration samples were prepared by adding PBDE and
PCB analytical standards (Accustandard, Inc., New Haven,
CT, USA) to 0.5 ml of control human serum purchased
from Sigma-Aldrich Corp. (St. Louis, MO, USA) to gener-
ate the following PBDE and PCB concentrations: 0.04, 0.1,
0.2, 0.8, 2, 4, 10, 20, and 50 ng/ml. Calibration samples were
processed following the same extraction method as
described for feline serum and plasma samples above.
Instrumentation and analysis of analytes
Samples extracts were analyzed for BDE-17, −28, −47,
−49, −52, −66, −85, −95, −99, −100, −153, −154, and
−183, and PCB-91, −95, −131, −135, −136, −153, −174,
−175, −176, −180, and −196 by gas chromatography
coupled with triple quadruple mass spectrometry (GC/
MS/MS, Scion TQ triple quadruple mass spectrometer
Bruker, Fremont, CA, USA). The detailed description for
sample preparation and GC-MS/MS parameters was re-
ported elsewhere [29]. Calibration curves were weighted
1/x. Two different ranges of the calibration standards were
used to quantify analytes to improve the linearity of cali-
bration curves. Initially, all analytes were quantified using
a calibration curve including standard concentrations of
0.04–20 ng/ml. Following analysis, analytes in any sample
calculated to exceed 20 ng/ml were then quantified using
a calibration curve including standard concentrations of
2–50 ng/ml. The lower limit of detection (LOD) and
quantification (LOQ) were established based on the lowest
calibrator with a signal-to-noise ratio of 3:1 and 10:1,
respectively. In order to facilitate the statistical analysis, a
non-detected congener was assigned a value of the corre-
sponding LOD divided by ½.
Quality control
The accuracy was assessed using the certified National
Institute of Standards and Technology (NIST) reference
standard serum SRM1957 (Gaithersburg, MD, USA) and
three quality control (QC) samples of human control
serum fortified with all PBDEs and PCBs at concentra-
tions of 0.2, 2 and 10 ng/ml. NIST and QC samples were
prepared following the same extraction method as de-
scribed for the feline samples and analyzed in parallel
with each group of feline samples. For each group of
samples processed and analyzed, the determined concen-
tration of each PBDE and PCB congener in the QC and
NIST samples, as quantified by the standard curves, was
required to fall within ±20% of the known concentration
of the individual congener for the data to be included in
the final analysis. The analytical laboratory participates
in the Artic Monitoring and Assessment Program (also
known as AMAP Ring Test of Persistent Organic Pollut-
ants in Human Serum) (CTQ 2014) for PBDEs analyses
and consistently showed excellent performance for
PBDE congener analysis with a Z-score < 2.
Lipid content determination
Total lipid content was calculated from measurements
of total cholesterol (TC) and total triglycerides (TG) in
each feline sample using standard enzymatic methods at
the UC Davis Health System Department of Pathology
and Laboratory Medicine [30, 31]. The TC and TG con-
centrations were used to calculate the total lipids (TL)
for each sample using the following equation: [32].
TL ¼ 2:27  TCð Þ þ TGþ 62:3 mg=dlð Þ
Statistical analysis
The concentrations of 13 PBDE and 11 PCB congeners in
feline serum and plasma samples were described using the
median values and the 10th and 90th percentiles. Logistic
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regression was used to analyze the association between
the presence/absence of feline hyperthyroidism and the
serum/plasma concentration of individual PBDE or PCB
congeners. The association of age and gender on the odds
of hyperthyroidism was investigated using Mann-Whitney
and chi-square tests of independence, respectively, to
determine whether these variables should be controlled
for in the logistic regression models. Lipid concentrations
were compared between groups using Student’s two-
group t-test.
The detection frequency (DFR) for each of the 13
PBDE and 11 PCB congeners assessed was determined
by calculating the percent of all measured samples in
which the concentration of the congener was above the
limit of detection. The sum concentration for PBDE and
PCB congeners was calculated for all the congeners mea-
sured (ƩPBDEs and ƩPCBs) and also for those with DFRs
of greater than 40% (ƩPBDE40 and ƩPCB40) in order to
investigate both the sum of all selected congeners and
the sum of those congeners that were more consistently
measured without influence from the less frequently de-
tected congeners. In our discussion, ƩPBDEs and ƩPCBs
were compared to previously reported measurements of
PBDEs and PCBs in a human population from a geo-
graphically similar area as part of a study conducted
by the National Health and Nutrition Examination
Survey [33].
For each PBDE and PCB congener, a logistic regres-
sion model, including congener concentration and age
as continuous (linear) variables, was used to analyze the
association of congener concentration with odds of
hyperthyroidism while controlling for the influence of
age. This model allowed statistically adjusting for age as
a confounder, so that the adjusted odds ratios reflect
the association strictly of the congener, rather than the
associations of both congener and age, on hyperthyroid
status. Results are reported as odds ratios and 95%
confidence intervals (CI). Due to large differences in
the median concentrations of different PBDE and PCB
congeners, the odds ratios (OR) for congeners with a
median serum concentration above 100 ng/g lipid in
the hyperthyroid group are presented corresponding to
a 100 ng/g lipid increase in congener concentration,
and the odds ratios for all remaining congeners are
presented corresponding to a 10 ng/g lipid increase in
congener concentration. The initial statistical analysis
was done using logistic regression in STATA data
analysis and statistical software (Stata IC/13, StataCorp
LP, College Station, TX, USA) which uses the standard
maximum-likelihood-based estimator. Due to the small
sample size, any congeners which yielded p-values less
than 0.10 were subsequently analyzed by exact logistic
regression using LogXact statistical software (Cytel
Software Corporation, Cambridge, MA, USA).
Results
Study population characteristics
The demographic characteristics of the hyperthyroid and
control feline study populations are summarized in Table 1.
A total of 20 hyperthyroid and 31 control cats were in-
cluded in the study. The median age of hyperthyroid cats
was 15 years (5th – 95th percentile, 11–18 years), com-
pared to a median of 12 years (5th – 95th percentile, 3–
20 years) in the control group. A Mann-Whitney rank sum
test indicated that age varied significantly between study
groups (p = 0.040); therefore, age was controlled for in sub-
sequent logistic regression analyses to assess the influence
of PBDE and PCB congener concentration on the risk of
hyperthyroidism. The percentage of males and females in
the control and hyperthyroid groups was not significantly
different, (χ2 (1) = 0.33, p = 0.56), thus it was not included
in the logistic regression analyses.
PBDE and PCB concentrations
The serum/plasma concentrations of 13 PBDE and 11
PCB congeners were determined and normalized to the
total lipid concentration for each feline sample. The total
lipids did not vary significantly between the hyperthyroid
and control groups (t (49) = −0.71, p = 0.48). Of the 13
PBDE congeners measured, the following 6 had detec-
tion frequencies (DFRs) of greater than 40%: BDE 47,
BDE 95, BDE 99, BDE 100, BDE 153, and BDE 154. Of
the 11 PCB congeners measured, the following five con-
geners had DFRs of greater than 40%: PCB 131, PCB
153, PCB 174, PCB 176, and PCB196. The sum of con-
centrations for PBDE and PCB congeners in all samples,
the control, and the hyperthyroid group was calculated
for all the congeners measured (ƩPBDEs and ƩPCBs)
and also for those with DFRs of greater than 40%
(ƩPBDE40 and ƩPCB40) (Additional file 1: Table S1).
The ƩPBDE40 and ƩPCB40 concentration values were
used to assess the association of total PBDE and PCB
concentration with feline hyperthyroidism.
Table 1 Comparison of population demographics and
characteristics between feline control and hyperthyroid study
groups
Variable Control (31) Hyperthyroid (20) p-value
Age – median
(5th–95th percentiles)
12 (3–20) 15 (11–18) 0.040
Gender – percent
Male 55 45 0.56
Female 45 55
Total lipids (g/ml) –
mean ± SD
0.0057 ± 0.002 0.0059 ± 0.001 0.22
Total T4 (μg/dl) –
mean ± SD
2.15 ± 0.68 8.24 ± 4.05 <.001
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The ƩPBDE40 had mean (±SE) and median (10–90
percentiles) concentrations of 4692 ng/g lipid (± 1.467 ng/
g lipid) and 812 ng/g lipid (38.3–8723 ng/g lipid), respect-
ively. The ƩPCB40 had mean (±SE) and median (10–90
percentile) concentrations of 497 ng/g lipid (± 158 ng/g
lipid) and 34.5 ng/g lipid (18.5–1251 ng/g lipid), respect-
ively (Additional file 1: Table S1). The distribution of
PBDE40 and ƩPCB40 concentrations for the hyperthy-
roid and control feline samples are shown in Fig. 2a and
given as a complete data set (Additional file 1: Table S1).
The mean and median values of the ƩPBDEs were higher
in the hyperthyroid group of feline samples compared to
the control group. For the ƩPCBs, the mean values were
higher in the hyperthyroid group; however, the medians
were similar. Logistic regression analysis was used to
examine the association of the ƩPBDE40 or ƩPCB40
concentrations with the occurrence of feline hyperthyroid-
ism, while controlling for the influence of age. An odds ra-
tio greater than one indicates that there is an association
between an increase in the ƩPBDEs or ƩPCBs concentra-
tions and the incidence of feline hyperthyroidism. The
odds ratios for a 100 ng/g lipid increase in ƩPBDE40 or
ƩPCB40 (Fig. 2b) were 1.000108 and 1.000885, respectively.
However, only the odds ratio for ƩPCB40 was statistically
significant (p < 0.05), indicating that an increase in the
serum or plasma concentration of ƩPCB40 is associated
with the occurrence of feline hyperthyroidism.
The distribution of individual PBDE and PCB con-
gener concentrations measured (ng/g lipid) in the hyper-
thyroid and control groups are shown in Fig. 3. The two
most abundant PBDE congeners were BDE 47 and BDE
99 (Fig. 3a). BDE 47 was detected in 78% of the feline
samples with a median concentration (10-90th percen-
tiles) of 497 ng/g lipid (0.7–4300 ng/g lipid) (Additional
file 1: Table S1). BDE 99 was detected in 82% of the
feline samples with a median concentration (10-90th
percentiles) of 570 ng/g lipid (0.0–5890 ng/g lipid). The
median values of BDE 47 and BDE 99 were higher in the
hyperthyroid group of feline samples compared to the
control group. The median (10–90 percentiles) values of
BDE47 were 328 ng/g lipid (0.8–1659 ng/g lipid) for the
control group compared to 698 ng/g lipid (0.7–6806 ng/g
lipid) for the hyperthyroid group. The median (10–90
percentiles) values of BDE99 were 179 ng/g lipid (0.0–
3807 ng/g lipid) for the control group and 995 ng/g lipid
(17.8–31,908 ng/g lipid) for the hyperthyroid group. The
two most abundant PCB congeners were PCB 153 and
PCB 180 (Fig. 3b). PCB153 was detected in 71% of the
feline samples with a median concentration (10-90th per-
centiles) of 78 ng/g lipid (1.2–1846 ng/g lipid) and PCB
180 was detected in 90% of the feline samples with a me-
dian (10-90th percentiles) of 175 ng/g lipid (26.5–909 ng/
g lipid). The median values of PCB153 and PCB180 were
higher in the hyperthyroid group of feline samples com-
pared to the control group. The median (10–90 percen-
tiles) values of PCB153 were 55 ng/g lipid (1.0–468 ng/g
lipid) for the control group compared to 1042 ng/g lipid
(2.2–2370 ng/g lipid) for the hyperthyroid group. The me-
dian (10–90 percentiles) values of PCB180 were 96 ng/g
lipid (1.8–481 ng/g lipid) for the control group and
653 ng/g lipid (47.6–1229 ng/g lipid) for the hyperthyroid
group. The median (10–90 percentiles), mean (± SE), and
DFR for each congener in all feline samples as well as the
hyperthyroid and control groups are given as a complete
data set (Additional file 1: Table S1).
Logistic regression analysis was utilized to determine
odds ratios for each PBDE and PCB congener, describing
the relationship between an elevated concentration of a
congener and the associated change in the odds of a
feline patient having hyperthyroidism. For clarity of data
Fig. 2 Distribution of ƩPBDEs and ƩPCBs concentrations in feline
samples and the odds ratios of feline hyperthyroidism associated
with a 100 ng/g lipid increase in ƩPBDEs and ƩPCBs. a Box and
whiskers diagrams of the ƩPBDEs and ƩPCBs concentrations shows
the distribution of measured concentrations (ng/g lipid) for control
(white boxes) and hyperthyroid (gray boxes) feline samples. Only
congeners with a detection frequency (DFR) greater than 40% were
included in the sum value. The upper and lower boundaries of the
boxes represent the 75th and 25th percentiles, respectively, and the
line within the boxes denotes the median value. The upper whiskers
show the 90th and the lower whiskers the 10th percentile. b Odds
ratios were determined by logistic regression analysis of the
relationship between ƩPBDEs and ƩPCBs and feline hyperthyroidism,
controlling for age of feline study participants. Error bars represent
the 95% confidence interval. An odds ratio that is significantly
greater than one indicates that an increase in the serum
concentration of the specific congener is associated with increased
odds of having feline hyperthyroidism. *p ≤ 0.05 in exact logistic
regression controlling for age of feline study participants
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interpretation, the odds ratios of the four most abundant
congeners, BDE47, BDE99, PCB153, and PCB180, are
presented corresponding to a 100 ng/g lipid increase in
serum or plasma concentration as each of these conge-
ners had a median greater than 100 ng/g lipid for the
hyperthyroid group (Fig. 4). The odds ratios, 95% confi-
dence intervals and associated p-values obtained from
logistic regression analysis are shown in Fig. 4 and pro-
vided as a complete data set (Additional file 1: Table S2).
Of the four congeners measured in highest abundance,
three of them, BDE47, PCB153, and PCB180, had
positive odds ratios that were significantly greater than
1.0 (p < 0.05), indicating that these associations were
unlikely to be due to chance in the absence of bias and
correctness of model specification. Specifically, the odds
ratios for BDE47, PCB153, and PCB180 were 1.06 [95%
confidence interval (CI), 1.00–1.13, p = 0.030], 1.29 (95%
CI, 1.04–2.13, p = 0.010), and 1.48 (95% CI, 1.06–2.42,
p = 0.014), respectively (Fig. 4). These odds ratios indi-
cate that a 100 ng/g lipid increase in the serum concen-
tration of BDE47, PCB153, or PCB180 is associated with
a 6.0%, 29%, and 48% increase, respectively, in the odds
of feline hyperthyroidism.
The less abundant PBDE and PCB congeners all had
median values below 100 ng/g lipid in the hyperthyroid
group, and their odds ratios are presented as the in-
crease in odds of hyperthyroidism associated with a
10 ng/g lipid increase in the serum concentration. The
odds ratios, 95% confidence intervals, and p-values
obtained from logistic regression analysis are shown in
Fig. 5 and given as a complete data set (Additional file 1:
Table S3). Among these less abundant congeners, six
additional BDEs and PCBs had positive odds ratios that
were significantly greater than 1.0 (p < 0.05): BDE17,
Fig. 3 Box and whiskers diagram of PBDE and PCB congener concentrations in feline samples. The distribution of measured concentrations of
each PBDE a and PCB b congener are given as lipid normalized values (ng/g total lipids) for control (white boxes) and hyperthyroid (gray boxes)
feline samples. The upper and lower boundaries of the boxes represent the 75th and 25th percentiles, respectively, and the line within the boxes
denotes the median value. The upper whiskers show the 90th and the lower whiskers the 10th percentile. *p ≤ 0.05 in exact logistic regression
controlling for age of feline study participants
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BDE49, BDE100, PCB131, PCBE174, and PCB196. The
odds ratio for a 10 ng/g lipid increase in serum concen-
tration was 1.83 (95% CI, 1.06–2.95, p = 0.021) for
BDE17, 1.72 (95% CI, 1.07–3.02, p = 0.021) for BDE49,
1.09 (95% CI, 1.01–1.19, p = 0.008) for BDE100, 1.77
(95% CI,1.08–3.68, p = 0.017) for PCB131, 1.05 (95% CI,
1.00–1.11, p = 0.042) for PCB174, and 1.17 (95% CI,
1.02–1.38, p = 0.029) for PCB196. These odds ratios
indicate that a 10 ng/g lipid increase in the serum con-
centrations of BDE17, BDE49, BDE100, PCB131, PCBE174,
or PCB196 is associated with an 83%, 72%, 9.0%, 77%,
5.0%, or 17% increase, respectively, in the odds of a feline
patient having hyperthyroidism.
Discussion
In this study, the serum or plasma concentrations of 13
PBDE and 11 PCB congeners were determined for 20
hyperthyroid and 31 control cats presented to the UC
Davis VMTH. PBDEs and PCBs were detected in all
samples, with BDE47, BDE99, PCB153, and PCB180
having the highest mean and median concentrations of
all the congeners. An exact logistic regression model
was utilized to determine whether the concentration of
individual congeners or the sum of congeners was corre-
lated with the incidence of feline hyperthyroidism (FH).
Exact logistic regression analysis indicated that increased
concentrations of BDE17, BDE47, BDE49, BDE100,
PCB131, PCB153, PCB174, PCB180, and PCB196 were
associated with diagnosis of feline hyperthyroidism. In
addition, the sum concentration of PCB congeners with
DFRs greater than 40% (ƩPCB40) was also correlated
with incidence of FH.
Feline hyperthyroidism has been thoroughly character-
ized and typically results from autonomous secretion of
excess THs from benign adenomas in the thyroid folli-
cles [9, 34]. However, the etiology of the disease and the
pathological development of thyroid adenomatous hy-
perplastic cells are not well understood. A combination
of immune, genetic, nutritional, and environmental fac-
tors have been hypothesized and studied; however, no
single dominant etiological factor has been identified.
Studies suggest that FH has a significant environmental
Fig. 4 Odds ratios and 95% CI of feline hyperthyroidism associated
with a 100 ng/g lipid increase in serum concentration of the four
most abundant PBDE and PCB congeners. Odds ratios were
determined by logistic regression analysis of the relationship
between serum concentrations of individual PBDE or PCB congeners
and feline hyperthyroidism, controlling for age of feline study
participants. Error bars represent the 95% confidence interval. An
odds ratio that is significantly greater than one indicates that an
increase in the serum concentration of the specific congener is
associated with increased odds of having feline hyperthyroidism.
*indicates a p-value ≤0.050
Fig. 5 Odds ratios and 95% CI of feline hyperthyroidism associated
with a 10 ng/g lipid increase in serum concentration of PBDE and
PCB congeners. Odds ratios were determined by logistic regression
analysis of the relationship between serum concentrations of
individual PBDE or PCB congeners and feline hyperthyroidism,
controlling for age of feline study participants. Error bars represent
the 95% confidence interval. An odds ratio that is significantly
greater than one indicates that an increase in the serum
concentration of the specific congener is associated with increased
odds of having feline hyperthyroidism. *indicates a p-value ≤0.050
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contribution, and exposure to thyroid-disrupting com-
pounds, such as PBDEs and PCBs, has been hypothesized
as a likely contributing factor [1, 18]. Both indoor lifestyle
and consumption of canned food have been linked to FH,
and each of these may contribute to the total body burden
of PBDEs and PCBs. The levels of PBDEs in dust from the
homes of hyperthyroid cats was significantly higher than
in dust from the homes of age-matched euthyroid control
cats [35], and the PBDE congener pattern was similar in
the serum of house cats and house dust samples [27],
indicating that house dust may be a dominant source of
PBDE exposure. In addition, PBDEs, PCBs, and some of
their metabolites have been detected in canned pet food
and may be a source of exposure [36]. Considering the
association of FH with indoor lifestyle and consumption
of canned food, it is important to keep in mind that ele-
vated BPDE and PCB exposure may merely be associated
with indoor lifestyle and/or canned food consumption and
that another associated factor is the true causal mechan-
ism of hyperthyroidism.
It has been a longstanding hypothesis that PBDEs and
PCBs contribute to the development of FH; however, pre-
vious studies of the relationship between serum or plasma
concentrations of PBDE and/or PCB congeners and
hyperthyroidism have generated variable results. While
some found no evidence linking PBDE or PCB profiles to
FH [25, 27], a few have reported indirect evidence linking
PBDE or PCB exposure to FH despite not identifying dif-
ferences in congener concentrations between hyperthyroid
and control cats. These include elevated PBDEs in dust
from houses containing hyperthyroid cats [35] and altered
ratios of BDE100/BDE99 in hyperthyroid cats [26]. Re-
cently, Norrgran et al. [39] identified three BDE congeners
(BDE99, BDE153, and BDE183) and one PCB congener
(PCB153) that were significantly higher in hyperthyroid
cats than control cats in Sweden. There are a number of
factors that may account for the variability in previously
reported results and may confound future studies. First,
the concentrations of PBDE and PCB congeners show
high variability within groups and most studies are limited
by small sample size. Both of these factors can greatly
limit the power of statistical analyses. In our study, an
exact logistic regression analysis was utilized to analyze
the correlation of congener concentrations to feline hyper-
thyroidism in order to prevent small-sample size bias that
may occur as a result of maximum likelihood estimation
of the normal logistic regression model. In addition, the
exact logistic regression does not assume normality or
equal variance. Thus, exact logistic regression analysis of
PBDE and PCB congener concentrations and their
relationship to FH provides a robust analysis for these
data. The individual PBDE and PCB congeners that are
measured and reported also vary by study, thus the
ƩPBDE and ƩPCB values reported are not consistent
between studies. While it is common practice to report
data only for congeners above a certain percent detection
frequency, this biases the analysis toward high abundance
congeners. This approach may prevent the identification
of low abundance congeners with TH-disrupting capabil-
ity. Thus, it is important to assess the potential impact of
all congeners detected and analyze the total PBDE and
PCB congeners as well as specific groups of high abun-
dance congeners that are routinely measured. This would
improve overall comparability between studies. In
addition, the PBDE and PCB profiles vary regionally, de-
pending on the technical mixtures that have been most
prominently used, thus congener collinearity also varies.
In our study, as well as several human studies conducted
in the U.S.A., BDE-47, −99, −100, −153, and −154 were
found in greatest concentration and are the primary com-
ponents of the penta-BDE mixture DE71, [37] a product
widely used in North America to treat polyurethane foam
in furniture to comply with California Technical Bulletin
117. In contrast, the most prevalent BDE congeners in fe-
line serum samples in Sweden were BDE209 and BDE207
with BDE99 accounting for only 13% total body burden,
compared to 44% in a U.S. population [28]. Therefore,
regional variability in PBDE congener profile will likely in-
fluence the collinearity of congeners in human or feline
samples, thus different congeners may be identified in
different populations as being associated with FH. For
PCBs, the congener profiles may be more consistent, as
PCB153 and PCB180 have been identified as the most
prevalent congeners in human serum [38], feline serum
[28], and in our study. However, variability in the con-
gener profiles may still contribute to inter-study variation.
PBDEs and PCBs each consist of 209 individual conge-
ners with slightly different structural conformations and
varying propensities to interfere with TH signaling and
feedback; therefore, we have examined the structure of the
congeners elevated in hyperthyroid feline samples to assess
potential structural patterns indicative of TH disruption.
Among these congeners (BDE17, BDE47, BDE49, BDE100,
PCB131, PCB153, PCB174, PCB180, and PCB196), all have
bromine or chlorine molecules located at the 2, 2′, and 4
positions on their benzene rings. Halogens in these posi-
tions create a structural pattern similar to the three iodine
molecules in the most active form of TH, triiodothyronine
(T3). Among the remaining fourteen congeners that were
not significantly elevated in the hyperthyroid group, six
had the same pattern of halogenation. However, two of
these congeners (PCB175 and PCB176) had p-values that
were near significant (0.055 and 0.071, respectively) and
another three (BDE99, BDE153, and BDE183) were previ-
ously identified as being elevated in a group of hyperthy-
roid cats [39]. It is possible that a study with a larger
sample size may show an association between these conge-
ners and feline hyperthyroidism; however, a more robust
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structure-activity relationship analysis would be necessary
to determine whether this halogenation pattern contributes
to the ability of specific PBDE and PCB congeners to inter-
fere with TH function. This information may be extremely
useful in identifying congeners that pose the greatest risk
for TH disruption and thyroid disease in both feline and
human populations.
PBDEs and PCBs have been implicated as TH disrup-
tors in both epidemiologic and laboratory studies. How-
ever, the relationship between PBDE exposure and
circulating TH levels is poorly understood, with many
human epidemiological studies presenting conflicting re-
sults [40–45], demonstrating both positive and negative
correlations with TH and TSH levels. A meta-analysis of
16 epidemiologic studies recently concluded that the re-
lationship between PBDE exposure and thyroid function
is dependent on the serum PBDE concentrations; there
was a negative correlation with TSH when median PBDE
levels were <30 ng/g lipid and a positive correlation
when PBDE levels were >100 ng/g lipid [46]. This pro-
posed u-shaped response curve suggests that multiple
mechanisms may contribute to the disruption of circu-
lating thyroid hormones that are likely dependent on
concentration and duration of exposure. Human epide-
miologic studies on PCB exposure have demonstrated
inverse correlations between exposure and circulating
THs in some but not all studies conducted [47–53].
While circulating levels of T4, T3, and TSH have
been classically used to evaluate endocrine disrupting
potential of PBDEs, PCBs, and other compounds,
these endpoints may not always predict a compound’s
TH-disrupting potential at a cellular level. In PCB-
exposed rodent populations with decreased circulating
T4, upregulation of the TH-responsive gene RC3 was
observed in the cerebral cortex [54], highlighting the
importance of evaluating the cellular mechanisms of
PBDE- and PCB-induced TH-disruption. TH disrup-
tion can occur at multiple levels of hormone action
including TH synthesis and release, transport through
circulation and across membranes, receptor mediated
gene expression, metabolism and clearance, and feed-
back in the pituitary [55, 56], thus PBDE-and PCB-
induced TH disruption may occur through multiple
mechanisms. Individual PBDE and/or PCB congeners
and their metabolites have demonstrated disrupting
potential through the following mechanisms: competi-
tive binding to TH serum transport protein transthyr-
etin (TTR), induction of glucuronidation and sulfation
enzymes, interference with TH membrane transporters
or intracellular deiodinases, and direct interference
with the TH receptor (TR) complex [57–65]. There
are significant gaps in the understanding of how each
of these mechanisms contributes to chronic PBDE or
PCB exposure and resulting TH disruption.
Previous studies, conducted on feline populations in
Sweden, Australia, and multiple locations within the
U.S.A., have measured serum PBDE concentrations
10–100 fold greater than median levels in adult human
populations from their respective countries. In con-
trast, the measured concentrations of PCBs in feline
serum samples are similar to those observed in human
populations. The population evaluated in this study
spans many cities in Northern California, USA, and the
concentrations of individual PBDE and PCB congeners
as well as the sum of congeners, ƩPBDEs and ƩPCBS,
measured are within a similar range as those previously
measured in a population of house cats from California’s
San Francisco Bay Area. As previously discussed by Guo
et al. [27], the levels of PBDEs that have been observed in
California house cats, are approximately 50 times higher
than in California human residents sampled in 2003 and
2004 in the National Health and Nutrition Examination
Survey, which are among the highest in the world [33].
Cats are likely to have an increased body burden of PBDEs
because of their reduced capacity to metabolize these
compounds via glucuronidation and increased exposure
to PBDE-containing furniture, textiles and house dust
[27, 66]. It is possible that chronic exposure to these
contaminants at the high levels observed in feline cir-
culation may lead to the development of autonomously
secreting hyperplastic cells through multiple mecha-
nisms of action, leading to hyperthyroidism.
With highly elevated exposure to PBDEs and similar
exposure to PCBs, house cats may experience the
effects of exposure to these pollutants more than
humans and other species with lower contaminant
levels. Thus, these highly exposed populations of
domestic cats can serve as sentinels for the adverse
health effects that may occur following prolonged ele-
vated exposure to these persistent organic pollutants.
FH is pathologically similar to the human condition of
toxic nodular goiter, as both conditions are character-
ized by the excessive production of THs from thyroid
follicles which is autonomous from TSH stimulation
[7]. This condition has only been observed in humans
and cats; therefore, FH may serve as a unique model
for the study of human toxic nodular goiter and its risk
factors. The identification of PBDE and PCB congeners
associated with thyroid disease among cats is also im-
portant within the broader field of environmental
health, due to the important roles that TH plays during
early development and throughout life. Disruption of
TH signaling during critical stages is likely to result in
abnormalities in neurodevelopment, growth, energy
balance, and reproduction [67]. Therefore, it is essen-
tial to develop a broader understanding of the risk that
PBDE and PCB exposure poses to the health of both
human and animal populations.
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Conclusions
This study demonstrates that elevated exposure to both
PBDE and PCB congeners is associated with FH, support-
ing the hypothesis that these persistent organic pollutants
may contribute to the etiopathogenesis of feline hyperthy-
roidism and suggests that they may have adverse impacts
on thyroid health in humans and other animal species.
However, the power of our study to detect possible associ-
ations with other congeners and potential risk factors, as
well as possible departures from linearity between con-
gener concentrations and the log odds of hyperthyroidism,
may have been limited by the small sample size and being
unable to obtain additional epidemiological data corre-
sponding to the feline patients included in the study. To
develop a more thorough understanding of the role that
PBDE and PCB body burden plays in the pathogenesis of
FH, longitudinal studies to determine the links between
exposures to PBDEs and PCBs and development of FH
from early life to elderly felines are needed. Thyroid hor-
mone function in the body is critical for proper execution
of many developmental processes and the function of
most organ systems throughout life across many species,
thus there are many adverse implications of TH disrup-
tion. The current and future progress among this field of
study will greatly contribute not only to our understand-
ing of feline hyperthyroidism, but also to human toxic
nodular goiter, and the adverse impacts of chemically-
induced TH-disruption that may affect human and animal
health spanning all life stages.
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